{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:49:08Z","timestamp":1791226148827,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Multidisciplinary Cooperative Diagnosis and Treatment Capacity","award":["lung cancer z027002"],"award-info":[{"award-number":["lung cancer z027002"]}]},{"name":"Advanced Lung Cancer Research Fund for targeted therapy in China","award":["CTONG-YC20210303"],"award-info":[{"award-number":["CTONG-YC20210303"]}]},{"name":"Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province","award":["CXPJJH121005-01"],"award-info":[{"award-number":["CXPJJH121005-01"]}]},{"name":"Health Research Project of Hunan Provincial Health Commission","award":["W20242005"],"award-info":[{"award-number":["W20242005"]}]},{"name":"Beijing Xisike Clinical Oncology and Research Foundation","award":["Y-HR2019-0185"],"award-info":[{"award-number":["Y-HR2019-0185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-024-01895-9","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:03:57Z","timestamp":1732619037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["An immune scoring system predicts prognosis and immune characteristics in lung adenocarcinoma brain metastases by RNA sequencing"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-5681","authenticated-orcid":false,"given":"Gang","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilong","family":"Tanzhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-0615","authenticated-orcid":false,"given":"Rongrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"issue":"9","key":"1895_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23(9):1447\u20131456","journal-title":"Neuro Oncol"},{"key":"1895_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","volume":"149","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology. Handb Clin Neurol 149:27\u201342","journal-title":"Handb Clin Neurol"},{"issue":"9","key":"1895_CR3","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/1078-0432.CCR-19-2184","volume":"26","author":"K Pocha","year":"2020","unstructured":"Pocha K et al (2020) Surfactant expression defines an inflamed subtype of lung adenocarcinoma brain metastases that correlates with prolonged survival. Clin Cancer Res 26(9):2231\u20132243","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1895_CR4","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/cncr.21545","volume":"104","author":"D Kondziolka","year":"2005","unstructured":"Kondziolka D et al (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104(12):2784\u20132791","journal-title":"Cancer"},{"issue":"1","key":"1895_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol AS et al (2019) Brain metastases. Nat Rev Dis Primers 5(1):5","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1895_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2217\/imt-2020-0262","volume":"13","author":"G Xiao","year":"2021","unstructured":"Xiao G et al (2021) Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application. Immunotherapy 13(12):1031\u20131051","journal-title":"Immunotherapy"},{"issue":"10","key":"1895_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41571-021-00520-1","volume":"18","author":"MJ Grant","year":"2021","unstructured":"Grant MJ, Herbst RS, Goldberg SB (2021) Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC. Nat Rev Clin Oncol 18(10):625\u2013644","journal-title":"Nat Rev Clin Oncol"},{"issue":"16","key":"1895_CR8","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1158\/1078-0432.CCR-20-0798","volume":"26","author":"I Eguren-Santamaria","year":"2020","unstructured":"Eguren-Santamaria I et al (2020) PD-1\/PD-L1 blockers in NSCLC brain metastases: challenging paradigms and clinical practice. Clin Cancer Res 26(16):4186\u20134197","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1895_CR9","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/annonc\/mdz207","volume":"30","author":"Y Kudo","year":"2019","unstructured":"Kudo Y et al (2019) Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer. Ann Oncol 30(9):1521\u20131530","journal-title":"Ann Oncol"},{"issue":"10","key":"1895_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002684","volume":"9","author":"BY Lu","year":"2021","unstructured":"Lu BY et al (2021) Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases. J Immunother Cancer 9(10):e002684","journal-title":"J Immunother Cancer"},{"issue":"11","key":"1895_CR11","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","volume":"75","author":"MW Teng","year":"2015","unstructured":"Teng MW et al (2015) Classifying cancers based on T-cell infiltration and PD-L1. Cancer Res 75(11):2139\u20132145","journal-title":"Cancer Res"},{"issue":"13","key":"1895_CR12","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/1759-7714.14473","volume":"13","author":"LL Li","year":"2022","unstructured":"Li LL et al (2022) An integrated biomarker of PD-L1 expression and intraepithelial CD8(+) T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases. Thorac Cancer 13(13):1948\u20131960","journal-title":"Thorac Cancer"},{"issue":"8","key":"1895_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A et al (2016) TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44(8):e71","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1895_CR14","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","volume":"10","author":"H Jung","year":"2019","unstructured":"Jung H et al (2019) DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun 10(1):4278","journal-title":"Nat Commun"},{"issue":"17","key":"1895_CR15","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S et al (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34(17):i884\u2013i890","journal-title":"Bioinformatics"},{"issue":"1","key":"1895_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321","journal-title":"Bioinformatics"},{"issue":"11","key":"1895_CR17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","volume":"28","author":"DS DeLuca","year":"2012","unstructured":"DeLuca DS et al (2012) RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28(11):1530\u20131532","journal-title":"Bioinformatics"},{"issue":"11","key":"1895_CR18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"1895_CR19","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH et al (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11","journal-title":"BMC Syst Biol"},{"key":"1895_CR20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612","journal-title":"Nat Commun"},{"issue":"1","key":"1895_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(1):509\u2013514","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1895_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F et al (2019) Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med 11(1):34","journal-title":"Genome Med"},{"issue":"1","key":"1895_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B et al (2016) Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol 17(1):174","journal-title":"Genome Biol"},{"key":"1895_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B et al (2018) Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol 1711:243\u2013259","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1895_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):218","journal-title":"Genome Biol"},{"issue":"1","key":"1895_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248\u2013262","journal-title":"Cell Rep"},{"issue":"1","key":"1895_CR27","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q et al (2022) The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Nat Commun 13(1):5983","journal-title":"Nat Commun"},{"issue":"10","key":"1895_CR28","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558","journal-title":"Nat Med"},{"issue":"1","key":"1895_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W et al (2016) Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell 165(1):35\u201344","journal-title":"Cell"},{"issue":"11","key":"1895_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y et al (2007) Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE 2(11):e1195","journal-title":"PLoS ONE"},{"issue":"8","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M et al (2017) IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest 127(8):2930\u20132940","journal-title":"J Clin Invest"},{"issue":"6411","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu R et al (2018) Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362(6411):eaar3593","journal-title":"Science"},{"issue":"3","key":"1895_CR33","doi-asserted-by":"publisher","first-page":"bbaa164","DOI":"10.1093\/bib\/bbaa164","volume":"22","author":"C Yang","year":"2021","unstructured":"Yang C et al (2021) Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology. Brief Bioinform 22(3):bbaa164","journal-title":"Brief Bioinform"},{"issue":"9","key":"1895_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE 9(9):e107468","journal-title":"PLoS ONE"},{"issue":"4","key":"1895_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385\u2013395","journal-title":"Stat Med"},{"issue":"1","key":"1895_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1):1\u201322","journal-title":"J Stat Softw"},{"issue":"43","key":"1895_CR37","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1038\/s41388-021-02019-6","volume":"40","author":"X Chen","year":"2021","unstructured":"Chen X et al (2021) CD8(+) T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer. Oncogene 40(43):6223\u20136234","journal-title":"Oncogene"},{"key":"1895_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-032713-120211","volume":"33","author":"JB Spangler","year":"2015","unstructured":"Spangler JB et al (2015) Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol 33:139\u2013167","journal-title":"Annu Rev Immunol"},{"issue":"200","key":"1895_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006504","volume":"5","author":"S Spranger","year":"2013","unstructured":"Spranger S et al (2013) Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci Transl Med 5(200):200ra116","journal-title":"Sci Transl Med"},{"issue":"12","key":"1895_CR40","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1002\/eji.1830241246","volume":"24","author":"B Huard","year":"1994","unstructured":"Huard B et al (1994) Lymphocyte-activation gene 3\/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. Eur J Immunol 24(12):3216\u20133221","journal-title":"Eur J Immunol"},{"issue":"1","key":"1895_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2018.06.007","volume":"49","author":"AC Lino","year":"2018","unstructured":"Lino AC et al (2018) LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity 49(1):120-133.e9","journal-title":"Immunity"},{"issue":"7528","key":"1895_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC et al (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515(7528):568\u2013571","journal-title":"Nature"},{"issue":"23","key":"1895_CR43","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-19-1344","volume":"25","author":"R Luo","year":"2019","unstructured":"Luo R et al (2019) Cisplatin facilitates radiation-induced abscopal effects in conjunction with PD-1 checkpoint blockade through CXCR3\/CXCL10-mediated T-cell recruitment. Clin Cancer Res 25(23):7243\u20137255","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1895_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","volume":"40","author":"E Limagne","year":"2022","unstructured":"Limagne E et al (2022) MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. Cancer Cell 40(2):136-152.e12","journal-title":"Cancer Cell"},{"issue":"7","key":"1895_CR45","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.7150\/thno.53649","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J et al (2021) Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics 11(7):3089\u20133108","journal-title":"Theranostics"},{"issue":"1","key":"1895_CR46","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1038\/s41467-019-10493-6","volume":"10","author":"D Henrik Heiland","year":"2019","unstructured":"Henrik Heiland D et al (2019) Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat Commun 10(1):2541","journal-title":"Nat Commun"},{"issue":"7","key":"1895_CR47","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","volume":"24","author":"N Priego","year":"2018","unstructured":"Priego N et al (2018) STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nat Med 24(7):1024\u20131035","journal-title":"Nat Med"},{"issue":"5","key":"1895_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","volume":"21","author":"SB Goldberg","year":"2020","unstructured":"Goldberg SB et al (2020) Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. Lancet Oncol 21(5):655\u2013663","journal-title":"Lancet Oncol"},{"issue":"4","key":"1895_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen T et al (2021) The genome sequence archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinform 19(4):578\u2013583","journal-title":"Genom Proteom Bioinform"},{"issue":"D1","key":"1895_CR50","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"Database Resources of the National Genomics Data Center","year":"2022","unstructured":"Database Resources of the National Genomics Data Center (2022) China National Center for Bioinformation in 2022. Nucleic Acids Res 50(D1):D27-d38","journal-title":"Nucleic Acids Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01895-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T12:07:18Z","timestamp":1732622838000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01895-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01895-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All tissues were collected with the approval of the ethics committee of Xiangya Hospital, Central South University (No.202207391).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}